| Authors: |
Koole S; Department of Gynaecology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., van Stein R; Department of Gynaecology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Sikorska K; Department of Biostatistics, Netherlands Cancer Institute, Amsterdam, Noord-Holland, The Netherlands., Barton D; Department of Gynaecological Oncology, Royal Marsden Hospital NHS Trust, London, UK., Perrin L; Queensland Centre for Gynaecological Cancer, Herston, Queensland, Australia., Brennan D; Gynaecology Oncology, Mater Misericordiae University Hospital, Dublin, Ireland., Zivanovic O; Department of Gynecologic Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Mosgaard BJ; Department of Gynaecology, Copenhagen University Hospital, Copenhagen, Denmark., Fagotti A; Dipartimento Scienze della Salute della Donna e del Bambino, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy., Colombo PE; Department of Surgical Oncology, Institut régional du Cancer de Montpellier, Montpellier, France., Sonke G; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Driel WJV; Department of Gynaecology, Netherlands Cancer Institute, Amsterdam, The Netherlands w.v.driel@nki.nl.; Center for Gynaecologic Oncology Amsterdam, Center for Gynaecologic Oncology Amsterdam, Amsterdam, The Netherlands.; Dutch Gynecological Oncology Group (DGOG), the Netherlands, the Netherlands.; Dutch Peritoneal Oncology Group (DPOG), the Netherlands, the Netherlands. |
